NICOLE MARTINEK: Open Payments
NPI 1679340426 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $561 · 2025 $427
Food & beverage: $340Education: $87
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| Daiichi Sankyo Inc. | 2 | $108 |
| PFIZER INC. | 4 | $64 |
| Celgene Corporation | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $20 |
| PharmaEssentia USA Corporation | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| ARRAY BIOPHARMA INC | 1 | $15 |
| Legend Biotech USA Inc. | 1 | $14 |
Products named: Enhertu, PLUVICTO, KISQALI, IBRANCE, XTANDI, REBLOZYL, INJECTAFER, Trodelvy.
Industry payments across OH — which companies pay providers there.
